Skip to content
Sunday 6 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,831.09
0.00%
DAX
26,046.40
+0.17%
CAC 40
8,278.77
-0.09%
STOXX 50
6,392.93
+0.16%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Tuesday 02 February 2016 1:46 pm

Mattioli Woods share price edges down despite profit at the Aim-listed wealth management company inching up for its six months ended November 2015

By: Hayley Kirton

Add as a preferred source on Google

Mattioli Woods has today revealed profit before tax of £2.8m for its six months ended November 2015, up 5.2 per cent from £2.7m for the same period the year before.

Revenue for the wealth management and employee benefits company also rose to £19.9m, up 20 per cent from £16.6m the year before.

Despite the uptick in profits, share price for the Aim-listed company has dropped slightly throughout the day, closing down 0.4 per cent for the day at 622.5p.

The company has made a number of acquisitions to help in grow recently, including three during the period for the reported results. The firm also acquired Maclean Marshall Healthcare this January.

Commenting on the results, Ian Mattioli, chief executive of Mattioli Woods, said that he was "delighted" with the growth the company had achieved and added:

"We are broadening our proposition as trusted adviser, product provider and asset manager and believe our blend of wealth management and employee benefits positions us well to deliver further strong shareholder returns going forward."

On the company's prospects for the remainder of the financial year, Mattioli added:

"Against a backdrop of volatile financial markets, regulatory and legislative change, in the second half of this financial year we expect sustained demand for advice from clients, offsetting any impact lower asset values have on investment-related revenues."

Meanwhile, Bob Woods, the company's executive chairman, who is due to stand down from the board in October but plans to stay on in an executive role, remarked:

"I am proud of the business I have helped create. Over the last 25 years a large part of our advice has been to assist our clients with their long term investment and succession planning."

However, the firm's repeating business has taken a knock over more recent months, with recurring income streams representing 81.6 per cent of the revenue for the six months to November 2015, compared to 82.1 per cent in the same period the year before.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Markets & Economics

Categories

  • Markets

Trending Articles

  • Budget tax hikes would be ‘road to ruin,’ Healey warned

  • Business confidence hits two-year high ahead of Budget

  • Reform UK donations sting ‘looks bad,’ admits Farage

  • No bailout for Jaguar Land Rover, says business secretary

  • Britain ‘taxing itself to death,’ Burnham warned

More from Morning Wire

  • IGI Reports Second Quarter and First Six Months of 2026 Unaudited Financial Results and Declares Ordinary Common Share Dividend

    Business Wire
  • Argan, Inc. Reports Second Quarter Fiscal 2027 Results

    Business Wire
  • L&G cheers push into private credit as profit jumps

    Markets
    Legal & General is reported to be eying Natwest's pension provider.
  • Techtronic Industries Delivers Strong First Half Performance

    Business Wire
  • Algoma Central Corporation Reports Financial Results for the 2026 Second Quarter

    Business Wire
  • Scheffler dethrones Woods as PGA Tour all-time top earner after 26 years

    Sport Business
    Scottie Scheffler, PGA Tour golfer, smiling next to the Tour Championship trophy with orange roses.
  • Aviva profits jump following Direct Line acquisition

    Insurance
    Aviva's deal to buy Direct Line was agreed in March
  • Silence Therapeutics Reports Second Quarter 2026 Financial and Business Results

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook